Data / Form D filings / SALIX PHARMACEUTICALS LTD
SALIX PHARMACEUTICALS LTD: Form D filing
SALIX PHARMACEUTICALS LTD, a pharmaceuticals company in Raleigh, NC, filed a Form D with the SEC in 2014. The latest, on January 10, 2014, reports $750 million sold of a $750 million offering to 7 investors.
Find out what SALIX PHARMACEUTICALS LTD does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 8510 Colonnade Center Drive, Raleigh, NC, 27615
- Phone
- (919) 862-1000
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Over $100,000,000
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1009356
The full lists. Form D filings in North Carolina: 984 rows, $49.20, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jan 10, 2014 | New notice | $750,000,000 | $750,000,000 | $0 | 7 | Dec 27, 2013 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Thomas W. D'Alonzo | Director | |
| William P. Forbes | Executive Officer | |
| John F. Chappell | Director | |
| Mark A. Sirgo | Director | |
| William P. Keane | Director | |
| Carolyn J. Logan | Executive Officer, Director | |
| Adam C. Derbyshire | Executive Officer | |
| Rick D. Scruggs | Executive Officer |
Other pharmaceuticals companies in North Carolina that filed recently
- Dignify Therapeutics, LLC $800,000 · Sep 25, 2026
Every Form D from the week of Jan 6, 2014 · All recent filings in North Carolina · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what SALIX PHARMACEUTICALS LTD reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.